Número 1 - EII al día

Enfermedades asociadas
37. Eade O, Smith C, Alexander J, et al. Pulmonary function in patients with
inflammatory bowel disease. Am J Gastroenterol 1980;73:154-6.
38. Heatley R, Thomas P, Prokipuch E, et al. Pulmonary functions abnormalities
in patients with inflammatory bowel disease. Q J Med 1982;51:241-250.
39. Kuzela L, Vavrecka A, Prikazska M et al. Pulmonary complications in
patients with inflammatory bowel disease. Hepatogastroenterology
1999;46:1714-9.
40. Douglas J, McDonald C, Leslie M et al. Respiratory impairment in inflammatory
bowel disease: does it vary with disease activity?. Respir Med
1989 Sep;83(5):389-94.
41. Louis E, Louis R, Drion V, et al. Increased frequency of bronchial hyperresponsiveness
in patients with inflammatory bowel disease. Allergy
1995;50:729-733.
42. Marvisi M, Borrello P, Brianti M, et al. Changes in the carbon monoxide
diffusing capacity of the lung in the ulcerative colitis. Eur Respir J 2000;
16:965-8
43. Mansi A, Cucchiara S, Greco L et al. Bronchial hyperrensponsiveness in
children and adolescents with Crohn´s disease. Am J Respir Crit Care Med
2000;161:1051-4.
44. Herringler K, Noftz K, Dalhoff K et al. Alterations in pulmonary function
in inflammatory bowel disease are frequent and persist during remission.
Am J Gastroenterol 2002;97:377-381.
45. Songur N, Songur Y, Tuzun M, et al. Pulmonary function tests and high
–resolution CT in the detection of pulmonary involvment in inflammatory
bowel disease. J Clin Gastroenterol 2003;37 (4):292-8.
46. Ceyhan BB, Karakurt S, Cevik H, et al. Bronchial hyperreactivity and allergic
status in inflammatory bowel disease.. Respiration 2003;70 (1) :60-6.
47. Robertson D, Taylor N, Sidhu H, et al. Pulmonary permeability in
celiac disease and inflammatory bowel disease. Digestion 1989;42:
98-103.
48. Gursoy S, Guven K, Kula M, Canoz O, Yurci A , Unluhizarci K, Ozbakir O,
Yucesoy M, Subclinical alveolar involvement in ulcerative colitis. Inflamm
Bowel Dis 2005;11(4):372-5.
49. Adenis A, Colombel J F, Lecouffe P, Wallaert B, Hecquet B, Marchandise
X, Cortot A, Increased pulmonary and intestinal permeability in Crohn’s
disease. Gut 1992 May;33(5):678-82.
50). Vennera MC, Picado C. Manifestaciones pulmonares de las enfermedades
inflamatorias intestinales. Arch Bronconeumol 2005;41 (2):93-
98.
51. Koek GH, Verleden GM, Evenepoel P, Rutgeerts P. Activity related increase
of exhaled nitric oxide in Crohn´s disease and ulcerarive colitis: a manifestation
of systemic involvement?. Respir Med 2002;96:530-5.
52. Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A, Lazarov E,
Fireman E. The Use of Induced Sputum in the assessment of pulmonary
involvement in Crohn´s dis.) Bonniere P, Wallaert B, Cortot A, et al.
Latent Pulmonary involvment en Crohn´s disease : biological,functional,
bronchoalveolar lavage and scintigraphic studies. Gut 1986;27:
919-25.
54. Wallaert B, Colombel JF, Tonnel A, Bonniere Ph, Cortot A, Paris JC, Voisin
C. Evidence of Lymphocite Alveolitis in Crohn´s disease. Chest 1985;87
(3):363-367.
55. Serra B, Hinojosa J, Martínez E, Fernández E, Molés JR, García J, Aragó
M. Pulmonary involvement in inflammatory bowel disease (IBD).
Gastroenterology 2005;128:A257 (Abst.)
37 • Enfermedad Inflamatoria Intestinal al día - Vol. 5 - Nº. 1 - 2006